Patents by Inventor Elisa Ciraolo

Elisa Ciraolo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases
    Patent number: 8841288
    Abstract: Compounds of Formula (I): able to inhibit kinase activity, in particular Phosphatidylinositol 3-Kinases activity. The disclosure also relates to the use of compounds of Formula (I) for treatment of pathological conditions associated to alterations in Phosphatidylinositol 3-Kinases activity.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: September 23, 2014
    Assignees: Universtà Degli Studi di Torino, Università Degli Studi del Piemonte Orientale “Amedeo Avogadro”
    Inventors: Giovanni Sorba, Gian Cesare Tron, Ubaldina Galli, Alberto Massarotti, Emilio Hirsch, Elisa Ciraolo, Tracey Pirali
  • QUINOLIN-4 (1H) -ONE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASES
    Publication number: 20130245005
    Abstract: Compounds of Formula (I): able to inhibit kinase activity, in particular Phosphatidylinositol 3-Kinases activity. The disclosure also relates to the use of compounds of Formula (I) for treatment of pathological conditions associated to alterations in Phosphatidylinositol 3-Kinases activity.
    Type: Application
    Filed: November 28, 2011
    Publication date: September 19, 2013
    Applicants: UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE "AMEDEO AVOGADRO", UNIVERSITA DEGLI STUDI DI TORINO
    Inventors: Giovanni Sorba, Gian Cesare Tron, Ubaldina Galli, Alberto Massarotti, Emilio Hirsch, Elisa Ciraolo, Tracey Pirali
  • Regulation of expression of PI3K? protein in tumors
    Patent number: 8105796
    Abstract: We describe the use of PI3K? protein and/or its encoding gene for the screening for substances useful in the treatment of cancers, preferably breast cancers, as well as a method for the diagnosis of malignant cell growth comprising the measuring the expression of PI3K?. We also describe non-human transgenic animals as models for studying human pathologies, preferably breast cancer, being transgenic for having altered PI3K? and Neu-T expression.
    Type: Grant
    Filed: February 12, 2008
    Date of Patent: January 31, 2012
    Assignee: Universita' Degli Studi di Torino
    Inventors: Emilio Hirsch, Guido Forni, Claudia Curcio, Elisa Ciraolo
  • REGULATION OF EXPRESSION OF PI3KBETA PROTEIN IN TUMORS
    Publication number: 20100192240
    Abstract: The present invention concerns the use of PI3K? protein and/or encoding gene for the screening for substances useful in the treatment of cancers, preferably breast cancers. The present invention also concerns a method for the diagnosis of malignant cell growth comprising the measuring the expression of PI3K? gene. The invention concerns also non-human transgenic animals as model study for human pathologies, preferably breast cancer, being transgenic for having altered PI3K? and Neu-T expression.
    Type: Application
    Filed: February 12, 2008
    Publication date: July 29, 2010
    Inventors: Emilio Hirsch, Guido Forni, Claudia Curcio, Elisa Ciraolo